These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37605227)

  • 21. Similar response patterns to topical minoxidil foam 5% in frontal and vertex scalp of men with androgenetic alopecia: a microarray analysis.
    Mirmirani P; Consolo M; Oyetakin-White P; Baron E; Leahy P; Karnik P
    Br J Dermatol; 2015 Jun; 172(6):1555-1561. PubMed ID: 25204361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-ablative Er:YAG laser is an effective tool in the treatment arsenal of androgenetic alopecia.
    Day D; McCarthy M; Talaber I
    J Cosmet Dermatol; 2022 May; 21(5):2056-2063. PubMed ID: 34435735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of platelet-rich plasma plus basic fibroblast growth factor combined with minoxidil in the treatment of androgenetic alopecia: A randomized controlled trial.
    Wu S; Liu S; Chen J; Dai D; Liu W; Le D; Guan Q; Miao Y; Hu Z; Qu Q
    J Cosmet Dermatol; 2023 Jul; 22(7):1995-2002. PubMed ID: 37195261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Injections of platelet-rich plasma prepared by automatic blood cell separator combined with topical 5% minoxidil in the treatment of male androgenetic alopecia.
    Wei W; Zhang Y; Long B; Zhang Y; Zhang C; Zhang S
    Skin Res Technol; 2023 Jul; 29(7):e13315. PubMed ID: 37522500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical observation of basic fibroblast growth factor (bFGF) combined with minoxidil in the treatment of male androgenetic alopecia.
    Liu C; Zhao H; Zhang Y; Wu W
    J Cosmet Dermatol; 2022 Sep; 21(9):4053-4059. PubMed ID: 35037386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Favorable effects of microneedling on long-standing androgenetic alopecia in an elderly man: A case report.
    Fujita J
    J Cosmet Dermatol; 2021 Feb; 20(2):588-590. PubMed ID: 32500595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial.
    Feldman PR; Fiebig KM; Piwko C; Mints BM; Brown D; Cahan DJ; Guevara-Aguirre J
    EClinicalMedicine; 2021 Oct; 40():101124. PubMed ID: 34541479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial.
    Feldman PR; Fiebig KM; Piwko C; Mints BM; Brown D; Cahan DJ; Guevara-Aguirre J
    EClinicalMedicine; 2021 Jul; 37():100978. PubMed ID: 34235415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-Level Light Therapy Downregulates Scalp Inflammatory Biomarkers in Men With Androgenetic Alopecia and Boosts Minoxidil 2% to Bring a Sustainable Hair Regrowth Activity.
    Mahe YF; Cheniti A; Tacheau C; Antonelli R; Planard-Luong L; de Bernard S; Buffat L; Barbarat P; Kanoun-Copy L
    Lasers Surg Med; 2021 Nov; 53(9):1208-1219. PubMed ID: 33973663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical minoxidil for androgenetic alopecia: optimizing the chance for success by appropriate patient selection.
    DeVillez RL
    Dermatologica; 1987; 175 Suppl 2():50-3. PubMed ID: 3691914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Australian trial of topical minoxidil and placebo in early male pattern baldness.
    Connors TJ; Cooke DE; De Launey WE; Downie M; Knudsen RG; Shumack S; Eggleston AS
    Australas J Dermatol; 1990; 31(1):17-25. PubMed ID: 2073205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical minoxidil therapy for hair regrowth.
    Rumsfield JA; West DP; Fiedler-Weiss VC
    Clin Pharm; 1987 May; 6(5):386-92. PubMed ID: 3311578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U; Hillmann K; Dietz E; Canfield D; Garcia Bartels N
    J Am Acad Dermatol; 2011 Dec; 65(6):1126-1134.e2. PubMed ID: 21700360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of a novel herbal solution for the treatment of androgenetic alopecia and comparison with 5% minoxidil: A double-blind, randomized controlled trial study.
    Masoud F; Alamdari HA; Asnaashari S; Shokri J; Javadzadeh Y
    Dermatol Ther; 2020 Nov; 33(6):e14467. PubMed ID: 33112463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized clinical trial comparing 5% and 1% topical minoxidil for the treatment of androgenetic alopecia in Japanese men.
    Tsuboi R; Arano O; Nishikawa T; Yamada H; Katsuoka K
    J Dermatol; 2009 Aug; 36(8):437-46. PubMed ID: 19691748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
    Gassmueller J; Hoffmann R; Webster A
    Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of female androgenetic alopecia with minoxidil 2%.
    Whiting DA; Jacobson C
    Int J Dermatol; 1992 Nov; 31(11):800-4. PubMed ID: 1428436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Randomized, Controlled Pilot Trial Comparing Platelet-Rich Plasma to Topical Minoxidil Foam for Treatment of Androgenic Alopecia in Women.
    Bruce AJ; Pincelli TP; Heckman MG; Desmond CM; Arthurs JR; Diehl NN; Douglass EJ; Bruce CJ; Shapiro SA
    Dermatol Surg; 2020 Jun; 46(6):826-832. PubMed ID: 31574029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of topical minoxidil therapy for androgenetic alopecia in women.
    Jacobs JP; Szpunar CA; Warner ML
    Int J Dermatol; 1993 Oct; 32(10):758-62. PubMed ID: 8225725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.